Sympathetically Mediated Changes in Capacitance: Redistribution of the Venous Reservoir as a Cause of Decompensation
暂无分享,去创建一个
[1] S. Massry,et al. Textbook of nephrology , 2013 .
[2] Michael Böhm,et al. Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart Failure: The Telemedical Interventional Monitoring in Heart Failure Study , 2011, Circulation.
[3] Symplicity Htn Investigators,et al. Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months , 2011, Hypertension.
[4] D. R. Wagoner. Chronic vagal nerve stimulation for the treatment of human heart failure: progress in translating a vision into reality. , 2011 .
[5] M. Zile,et al. Hemodynamic factors associated with acute decompensated heart failure: part 1--insights into pathophysiology. , 2011, Journal of cardiac failure.
[6] R. Canby,et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). , 2011, Congestive heart failure.
[7] L. Stevenson,et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.
[8] J. McMurray,et al. Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.
[9] D. V. Van Wagoner,et al. Chronic vagal nerve stimulation for the treatment of human heart failure: progress in translating a vision into reality. , 2011, European heart journal.
[10] D. Mann,et al. The vagus nerve and autonomic imbalance in heart failure: past, present, and future , 2011, Heart Failure Reviews.
[11] H. Krum,et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.
[12] William T. Abraham,et al. Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.
[13] R. Verrier,et al. Heart rate, autonomic markers, and cardiac mortality. , 2009, Heart rhythm.
[14] Y. Takei,et al. Value of the extracellular water ratio for assessment of cirrhotic patients with and without ascites , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[15] G. Breithardt. MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure , 2009, European heart journal.
[16] Christopher Zimmer,et al. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. , 2009, European heart journal.
[17] Gary S Francis,et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.
[18] G. Fink. Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure. , 2009, Hypertension.
[19] J. Sharman,et al. Effects of bradykinin on venous capacitance in health and treated chronic heart failure , 2008, Clinical science.
[20] E. Rackow. Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.
[21] J. Bates,et al. A further analysis of why pulmonary venous pressure rises after the onset of LV dysfunction. , 2009, Journal of applied physiology.
[22] M. Zile,et al. Transition From Chronic Compensated to Acute Decompensated Heart Failure: Pathophysiological Insights Obtained From Continuous Monitoring of Intracardiac Pressures , 2008, Circulation.
[23] Brian Olshansky,et al. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. , 2008, Circulation.
[24] S. Gelman,et al. Venous Function and Central Venous Pressure: A Physiologic Story , 2008, Anesthesiology.
[25] M. Zile,et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.
[26] G. Burnstock,et al. Sympathetic Innervation of Human Mesenteric Artery and Vein , 2008, Journal of Vascular Research.
[27] M. Gheorghiade,et al. Fluid overload in acute heart failure — Re‐distribution and other mechanisms beyond fluid accumulation , 2008, European journal of heart failure.
[28] J. Concato,et al. Patterns of Weight Change Preceding Hospitalization for Heart Failure , 2007, Circulation.
[29] J. McMurray,et al. Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function , 2007, European journal of heart failure.
[30] G. Fink,et al. Splanchnic Circulation Is a Critical Neural Target in Angiotensin II Salt Hypertension in Rats , 2007, Hypertension.
[31] K. Swedberg,et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. , 2007, JAMA.
[32] M. Guglin,et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. , 2007, Journal of the American College of Cardiology.
[33] K. Weber,et al. Effect of Timed Semirecumbency and Furosemide Dosing on Urinary Sodium Excretion in Patients with Compensated Heart Failure , 2006, The American journal of the medical sciences.
[34] Allen W. Cowley,et al. Systems analysis of arterial pressure regulation and hypertension , 1972, Annals of Biomedical Engineering.
[35] Ralph D'Agostino,et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. , 2004, The New England journal of medicine.
[36] W. Abraham,et al. Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device , 2004, Circulation.
[37] R. Hainsworth,et al. Phasic negative intrathoracic pressures enhance the vascular responses to stimulation of pulmonary arterial baroreceptors in closed‐chest anaesthetized dogs , 2004, The Journal of physiology.
[38] S. Gelman,et al. Catecholamine-induced changes in the splanchnic circulation affecting systemic hemodynamics. , 2004, Anesthesiology.
[39] Robert A McNutt,et al. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. , 2003, The American journal of medicine.
[40] P. Poole‐Wilson,et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.
[41] D. Duprez,et al. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy. , 2002, Journal of the American College of Cardiology.
[42] D. DeMets,et al. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.
[43] P. Agostoni,et al. Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure , 2002, European journal of heart failure.
[44] T. Nozawa,et al. Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats , 2002, Heart and Vessels.
[45] M. Frenneaux,et al. Preservation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction. , 2001, Journal of the American College of Cardiology.
[46] S. Goldstein,et al. The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF Trial. , 1999, Clinical cardiology.
[47] B. Lévy,et al. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. , 1998, Circulation research.
[48] G. MacGregor,et al. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines. , 1998, Clinical science.
[49] J. McMurray,et al. Catecholamines contribute to exertional dyspnoea and to the ventilatory response to exercise in normal humans. , 1997, European heart journal.
[50] J. Huidobro-Toro,et al. Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation. , 1997, European journal of pharmacology.
[51] D. Sica,et al. Treatment with enalapril fails to prevent impaired cardiopulmonary baroreflex control in dogs with left ventricular dysfunction. , 1995, Journal of cardiac failure.
[52] M. Dibner-dunlap,et al. Altered vagal and sympathetic control of heart rate in left ventricular dysfunction and heart failure. , 1995, The American journal of physiology.
[53] D. Burkhoff,et al. Why does pulmonary venous pressure rise after onset of LV dysfunction: a theoretical analysis. , 1993, The American journal of physiology.
[54] M. Thames,et al. Abnormalities of baroreflex control in heart failure. , 1993, Journal of the American College of Cardiology.
[55] J. Cohn,et al. Plasma Norepinephrine, Plasma Renin Activity, and Congestive Heart Failure Relations to Survival and the Effects of Therapy in V‐HeFT II , 1993, Circulation.
[56] C. Rothe,et al. Mean circulatory filling pressure: its meaning and measurement. , 1993, Journal of applied physiology.
[57] M. Thames,et al. Control of Sympathetic Nerve Activity by Vagal Mechanoreflexes Is Blunted in Heart Failure , 1992, Circulation.
[58] S. Yusuf,et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. , 1992, Circulation.
[59] P. Schwartz,et al. Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs. , 1991, The American journal of physiology.
[60] ON BEDRESTING IN HEART FAILURE , 1990, The Lancet.
[61] D L Eckberg,et al. Autonomic pathophysiology in heart failure: carotid baroreceptor-cardiac reflexes. , 1990, The American journal of physiology.
[62] U. Dahlström,et al. Neuroendocrine response in acute heart failure and the influence of treatment. , 1989, European heart journal.
[63] M. Thames,et al. Baroreflex Control of Renal Sympathetic Nerve Activity Is Preserved in Heart Failure Despite Reduced Arterial Baroreceptor Sensitivity , 1989, Circulation research.
[64] L. Stevenson,et al. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.
[65] J. Firth,et al. RAISED VENOUS PRESSURE: A DIRECT CAUSE OF RENAL SODIUM RETENTION IN OEDEMA? , 1988, The Lancet.
[66] D. Karnad,et al. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. , 1986, British medical journal.
[67] R. Hainsworth,et al. Vascular capacitance: its control and importance. , 1986, Reviews of physiology, biochemistry and pharmacology.
[68] N. Christensen,et al. Bed rest and increased diuretic treatment in chronic congestive heart failure. , 1985, European heart journal.
[69] M. Packer,et al. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. , 1985, Circulation.
[70] W. Ammons,et al. Neural and vascular interaction in renin response to graded renal nerve stimulation. , 1982, The American journal of physiology.
[71] F. Ingelfinger,et al. The effect of the upright posture upon hepatic blood flow in normotensive and hypertensive subjects. , 1951, The Journal of clinical investigation.